Clobetasol

Clobetasol

SCHEMBL13046611

C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 8/20 0.85
CYP3A4 P08684 7/20 0.85
HIF1A Q16665 7/20 0.85
HSD17B10 Q99714 3/20 0.85
NFKB1 P19838 3/20 0.85
PGR P06401 3/20 0.85
TSHR P16473 2/20 0.85
AR P10275 2/20 0.85
PMP22 Q01453 2/20 0.85
MEN1 O00255 1/20 0.85
CYP2D6 P10635 1/20 0.85
KMT2A Q03164 1/20 0.85
APEX1 P27695 1/20 0.85
NPSR1 Q6W5P4 1/20 0.85
IKBKB O14920 1/20 0.85
CHUK O15111 1/20 0.85
ADRB2 P07550 1/20 0.85
NR3C2 P08235 1/20 0.85
PLA2G2A P14555 1/20 0.85
NFKB2 Q00653 1/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Clobetasol SCHEMBL1651129 1.00 NR3C1 (0.85) NR3C1CYP3A4HIF1AHSD17B10NFKB1
Clobetasol SCHEMBL8602501 1.00 NR3C1 (0.85) NR3C1CYP3A4HIF1AHSD17B10NFKB1
Clobetasol SCHEMBL7616575 1.00 NR3C1 (0.85) NR3C1CYP3A4HIF1AHSD17B10NFKB1
Clobetasol SCHEMBL3996 1.00 NR3C1 (0.85) NR3C1CYP3A4HIF1AHSD17B10NFKB1
Clobetasol SCHEMBL5034388 1.00 NR3C1 (0.85) NR3C1CYP3A4HIF1AHSD17B10NFKB1
Clobetasol SCHEMBL30915305 1.00 NR3C1 (0.85) NR3C1CYP3A4HIF1AHSD17B10NFKB1
Clobetasol SCHEMBL19327129 1.00 NR3C1 (0.85) NR3C1CYP3A4HIF1AHSD17B10NFKB1
Clobetasol SCHEMBL5034390 1.00 NR3C1 (0.85) NR3C1CYP3A4HIF1AHSD17B10NFKB1
Clobetasol SCHEMBL28167282 0.99 NR3C1 (0.83) NR3C1CYP3A4HIF1AHSD17B10NFKB1
Dexamethasone SCHEMBL20770143 0.97 HIF1A (0.92) NR3C1CYP3A4HIF1AHSD17B10NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE46190-E1 High-molecular weight conjugate of steroids NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2016-11-01 US disclosed
US-RE46190-E1 High-molecular weight conjugate of steroids NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2016-11-01 US disclosed
US-8703878-B2 High-molecular weight conjugate of steroids NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2014-04-22 US disclosed
US-8703878-B2 High-molecular weight conjugate of steroids NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2014-04-22 US disclosed
US-20100292414-A1 High-Molecular Weight Conjugate Of Steroids NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2010-11-18 US disclosed
US-20100292414-A1 High-Molecular Weight Conjugate Of Steroids NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2010-11-18 US disclosed
EP-2206502-A1 POLYMER CONJUGATE OF STEROID Nippon Kayaku Kabushiki Kaisha (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292414-A1 High-Molecular Weight Conjugate Of Steroids CYP17A1, CYP21A2, HSD17B12 NR3C1 74/4885CYP3A4 149/4885HIF1A 2922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.